Clinical Trial Update: A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II) [Phase 4]

View source ↗

Summary

A Phase 4 trial of Elaprase (idursulfase) in treatment-naïve patients with Hunter syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis

Drugs mentioned

• Elaprase (idursulfase)

Snippet

Sponsor: Takeda | Conditions: Mucopolysaccharidosis (MPS), Hunter Syndrome | Phase 4 | Status: WITHDRAWN